Genomenon Report Reveals Gene Fusion Data a Critical Factor in Cancer Diagnostics and Drug Development

Genomenon has released a research report detailing clinically significant fusion genes reported through April 2019. Fusion genes have long been known to play an... Read More

Precision Medicine changing how value is created and delivered in biopharmaceutical and diagnostics industries

Newsweek has released the results of a new report on precision medicine from their Vantage Thought Leadership division. The report, entitled Precision Medicine: Creating... Read More

GNS Healthcare Raises $23 Million Led by Cigna Ventures

GNS Healthcare (GNS), a leading precision medicine company, today announced a $23 million Series D fundraising round, led by Cigna Ventures, a strategic corporate... Read More

Agilent to Acquire BioTek, Strengthening Leadership Position in Growing Cell Analysis Segment

Agilent Technologies Inc. (NYSE: A) has announced it has signed a definitive agreement to acquire privately-owned BioTek Instruments for $1.165 billion. With anticipated tax... Read More

Be The Match BioTherapies® and Tmunity Announce Collaboration to Support Clinical Trials of Next-Generation Immunotherapies

–Be The Match BioTherapies®, an organization offering solutions for companies developing and commercializing cell and gene therapies, and Tmunity Therapeutics, Inc., a private clinical-stage... Read More

AmerisourceBergen Announces Long-Term Strategic Relationship with OneOncology

VALLEY FORGE, Pa.–(BUSINESS WIRE)–AmerisourceBergen, a global healthcare solutions leader, today announced that it has entered a long-term strategic relationship with OneOncology, the national partnership... Read More

Tumor Mutation Burden Study Shows Viability of In-House Testing

As laboratories increasingly look to bring advanced molecular testing in-house, the results of a new retrospective clinical research study show that tumor mutation burden... Read More

Guardant Health Announces Commercial Payer Progress with more than 150 Million Lives Covered for Guardant360

Guardant Health, Inc. (Nasdaq: GH), announced that its market leading liquid biopsy, Guardant360®, will be a covered benefit for the members of the health... Read More

SomaLogic announces new collaboration with Janssen Research & Development

SomaLogic, Inc. has announced that it has entered into a collaborative agreement with Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies... Read More

FH Foundation Expands FIND FH® to Speed Diagnosis of Individuals with Homozygous Familial Hypercholesterolemia

The FH Foundation recently announced the launch of the FIND HoFH program to identify individuals at risk for homozygous familial hypercholesterolemia (HoFH). The goal... Read More

SOPHiA GENETICS Achieves CE-IVD Milestone for Its Solid Tumor Solution for Accurate Cancer Detection

SOPHiA GENETICS, global leader in Data-Driven Medicine, announced today the CE-IVD marking of its Solid Tumor Solution (STS), a new step in the fight... Read More

PerkinElmer Genomics Introduces Physician-Ordered Genetic Screening Test for Proactive Health Management

Today, in collaboration with Helix, PerkinElmer, Inc., a global leader committed to innovating for a healthier world, launched GenePrism: Actionable Insights, a new genetic... Read More

Pat Basu, MD, MBA, named President and Chief Executive Officer of Cancer Treatment Centers of America

BOCA RATON, Fla., April 3, 2019 /PRNewswire/ — Pat A. Basu, MD, MBA, an accomplished health care executive and entrepreneur, has been appointed President... Read More

Roche launches NAVIFY Mutation Profiler and NAVIFY Therapy Matcher to support comprehensive genomic profiling in cancer

• CE-IVD marked software as a medical device that aids clinicians to more easily interpret NGS oncology tests • Classifies detected variants in accordance... Read More

Thermo Fisher Scientific to Acquire Brammer Bio, a Leader in Viral Vector Manufacturing

WALTHAM, Mass. and CAMBRIDGE, Mass., March 24, 2019 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and Brammer... Read More

Multi-Year Agreement Broadens Uses of Real-World Evidence and Accelerates Precision Oncology Innovations

    Bristol-Myers Squibb and Concerto HealthAI, a market leader in oncology-specific Real-World Data (RWD) and advanced Artificial Intelligence (AI)-enabled insight solutions for Real-World... Read More

Scientists Engineer New CRISPR Platform for DNA Targeting

CRISPR team harnesses new Cas12b enzyme for use in eukaryotic cells, adding to the CRISPR toolbox. A team that includes the scientist who first... Read More

Carrie Ann Inaba Partners with Daiichi Sankyo, Inc. to Encourage Americans to “Get Iron Informed”

Daiichi Sankyo, Inc. today announced a partnership with dancer, choreographer and TV host Carrie Ann Inaba on Get Iron Informed, a campaign to raise... Read More

New Study to Focus on Unique Needs of Acute Myeloid Leukemia Patients

The Cancer Support Community (CSC), a global nonprofit, is launching a unique research study focused on individuals diagnosed with Acute Myeloid Leukemia (AML), a... Read More

PHC Holdings Signs Agreement to Acquire Anatomical Pathology Business from Thermo Fisher Scientific

PHC Holdings Corporation (headquarters: Tokyo, Japan, hereafter PHCHD) has announced that it has signed a definitive agreement with Thermo Fisher Scientific Inc. (NYSE: TMO,... Read More

Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2018

Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the fourth quarter and fiscal year 2018. Fourth quarter 2018 results: Revenue of $867... Read More

ArcherDX Acquires Baby Genes, a Genetics-Based Personalized Medicine Company

ArcherDX, Inc., a molecular technology company dedicated to developing breakthrough solutions that advance the application of personalized genomic medicine, is pleased to announce the... Read More

Diaceutics Opens Asian Hub to Capitalize on Growing Market

Diaceutics, the diagnostics data analytics and implementation services company, today announces that it is opening a new regional hub in Asia. With more than... Read More

Roche Launches uPath Enterprise Software with Improved Speed, Performance and Usability for Digital Pathology

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of its innovative uPath enterprise software[1] for digital pathology. Offering a new standard of... Read More

QIAGEN acquires N-of-One, expanding its clinical bioinformatics capabilities in molecular oncology decision support

Enhancing QIAGEN’s industry-leading position with access to MarkerMine™ database and real-world evidence insights that provide insights for targeted therapy options QIAGEN N.V. has announced... Read More

Genetic Alliance and LunaPBC Partner to Support Personal Health and Accelerate Medical Breakthroughs

LunaPBC, founder of LunaDNA, the first community-owned genomic and health data platform, announced today its partnership with Genetic Alliance, a non-profit dedicated to providing... Read More

XIFIN Enters Precision Medicine Informatics Market with the Launch of VisualStrata®

XIFIN, Inc. has unveiled VisualStrata, the only precision medicine informatics platform that curates and visualizes diagnostic, clinical and financial data to document the patient... Read More

Genomenon announced that it has published the first Cited Variant Reference (CVR)

Genomenon announced that it has published the first Cited Variant Reference (CVR), a comprehensive catalogue of genetic variants cited in the medical literature. The... Read More

BIO2018: Robin Roberts, Diana Ross and Record-breaking Partnering

As BIO celebrates its 25-year anniversary, the upcoming BIO International Convention June 4-7 at the Boston Convention and Exhibition Center will highlight the organization’s... Read More

LifeX™ Health Solutions Platform Opens Headquarters – Announces $2 million Henry L. Hillman Foundation grant

LifeX™, as part of Life Sciences Week 2018, celebrated the opening of its first headquarters, where it will provide expertise and working space to... Read More

Thermo Fisher Scientific Launches Oncomine Childhood Cancer Research Assay and Establishes International Childhood Oncology Network

One in 285 children born in the U.S. this year alone will be diagnosed with cancer before their 20th birthday1, yet, until recently, too... Read More

Nicklaus Children’s Hospital, in collaboration with Rady Children’s Institute for Genomic Medicine and Sanford Health, has launched two genomic medicine research protocols to more effectively diagnose and treat children with unexplained illnesses.

Nicklaus Children’s Hospital, in collaboration with Rady Children’s Institute for Genomic Medicine and Sanford Health, has launched two genomic medicine research protocols to more... Read More

Opdivo Plus Low-Dose Yervoy Combination Reduces the Risk of Progression or Death…

Bristol-Myers Squibb  announced initial results from the pivotal Phase 3 study, CheckMate -227, evaluating the Opdivo (nivolumab) 3 mg/kg plus low-dose Yervoy (ipilimumab, 1... Read More

PierianDx Forms Strategic Partnership with Leading Research and Technical Services Organization RTI International

PierianDx, the leading genomics technology company that enables precision medicine, announced today a strategic partnership with RTI International to help solve the problem of... Read More

CIGNA TO ACQUIRE EXPRESS SCRIPTS FOR $67 BILLION

Cigna Corporation (NYSE: CI) and Express Scripts Holding Company (NASDAQ: ESRX) today announced that they have entered into a definitive agreement whereby Cigna will... Read More

Foundation Medicine Announces 2017 Fourth Quarter and Year-End Results

Foundation Medicine reported financial and operational results for the fourth quarter and year ended December 31, 2017. Highlights for the quarter and year included:... Read More

PierianDx Launches Clinical Genomics Services to Accelerate Precision Medicine

PierianDx, the leading genomics technology company that enables precision medicine, announced today a full range of expanded services to support adoption of the company’s... Read More

2bPrecise and The Innovation Institute to Deliver Robust Pharmacogenomics Platform, GeneFolio, to the Point of Care

2bPrecise®, LLC, and The Innovation Institute announced today that they have entered into an agreement that lays the foundation for 2bPrecise to deliver a... Read More

Allscripts launches industry’s first machine learning EHR

Allscripts Healthcare Solutions (NASDAQ:MDRX) unveiled its new electronic health record (EHR), Avenel™, at the annual HIMSS conference today. Mobile-first and cloud-based, Avenel creates a... Read More

BC Platforms Launches an End-to-end Solution for Precision Medicine Powered by the Microsoft Genomics Service

BC Platforms, a pioneer in genomic data management and analytics, today announces it has launched GeneVision, a new end-to-end Solution for Precision Medicine that... Read More

Baylor Genetics Expands Its Precision Medicine Portfolio With ClariFind.

Baylor Genetics announced the launch of ClariFind, a comprehensive somatic tumor next-generation sequencing test that correlates genomic results with specific drug therapies and clinical... Read More

Atos Transforms Value-based Healthcare with Digital Health Solutions

Atos, a global leader in digital transformation, continues to strengthen its North America digital healthcare portfolio with services that help enable the shift to... Read More

Orion Health Unveils New Predictive Intelligence Using Machine Learning to Help Save Billions in Healthcare Costs

Orion Health™ has announced its machine learning service, Amadeus Intelligence, designed to help the health sector reduce operating costs and improve patient care. Led... Read More

Tempus and NYU School of Medicine Announce New Initiative to Help Improve Outcomes for Pancreatic Cancer Patients

Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data, today announced... Read More

Luna DNA Announces Dawn Barry, former Illumina VP, as President

Luna DNA, the first and only genomic and medical research knowledge base powered by the blockchain and owned by its community, announced today Dawn... Read More

Clinical Genomics appoints Tadd Lazarus, MD, as Chief Medical Officer

Clinical Genomics, a leading provider of cancer diagnostic solutions and liquid biopsy tests, today announced the appointment of Tadd Lazarus, M.D., as Chief Medical... Read More

Roche and GE enter partnership to develop integrated digital diagnostics platform to improve oncology and critical care treatment

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it has entered into a strategic, long-term partnership with GE Healthcare in order to jointly develop... Read More

Oncologists Can Now Specify Cancer Treatment Options to Score and Rank with CureMatch

CureMatch® will present the new release of PreciGENE™ Personalized Combination Therapy® at Biotech Showcase™ 2018, to be held January 8–10 in San Francisco. Oncologists... Read More

Renowned Scientists Join Rady Children’s Institute for Genomic Medicine Scientific Advisory Board

The Rady Children’s Institute for Genomic Medicine (RCIGM) is pleased to announce that six influential life science researchers have been recruited to serve on... Read More

Patients Can Now Request a OneOme RightMed® Test Through an Independent Provider Network

Precision medicine company OneOme is partnering with PWNHealth to increase patient access to the RightMed® comprehensive test without compromising patient safety. Until now, patients... Read More